Surgery
Surgery is the main treatment for most localised uterine sarcomas. A total hysterectomy removes the uterus and cervix. The aim is to remove the tumour completely and intact without cutting or disrupting it.
Supportive Care for Every Step of Your Uterine Sarcoma Treatment
From diagnosis and treatment planning to surgery, recovery and long-term follow-up, experience care that considers your strength, nutrition, hormonal health, comfort and overall wellbeing.
About Uterine Sarcoma
A diagnosis can bring many questions at once. Let us begin with the basics.
Uterine sarcoma is a rare cancer that develops in the muscle or supporting tissues of the uterus. It differs from endometrial cancer, which begins in the uterine lining and is much more common. Major types include uterine leiomyosarcoma, low-grade and high-grade endometrial stromal sarcoma, undifferentiated uterine sarcoma and uterine adenosarcoma. Rare molecularly defined sarcomas can also occur. Symptoms may include abnormal vaginal bleeding, pelvic or abdominal pain or pressure, a pelvic mass or increasing abdominal size. Leiomyosarcoma can sometimes resemble a benign fibroid on imaging. The exact tumour type, stage, molecular features and specialist pathology findings are important for determining the most appropriate treatment approach.
Understanding Conventional Uterine Sarcoma Treatments
Treatment should ideally be planned by a team experienced in both gynaecologic oncology and sarcoma because management differs considerably between subtypes.
Why Morcellation Matters
Morcellation breaks uterine tissue into smaller pieces for removal. It should be avoided when sarcoma is suspected because disruption of an unsuspected sarcoma may spread tumour cells within the abdomen, complicate staging and increase recurrence risk. If sarcoma is unexpectedly diagnosed after surgery for a presumed fibroid, expert pathology review, imaging and discussion of additional surgery or treatment may be required.
Ovarian Management
Removal of both ovaries and fallopian tubes is commonly considered in postmenopausal patients. Ovarian preservation may be possible for selected premenopausal patients with early-stage disease. The decision is especially important in hormone-sensitive cancers such as low-grade endometrial stromal sarcoma.
Lymph Nodes
Routine removal of normal-looking lymph nodes is not recommended for most uterine sarcomas. Suspicious or enlarged nodes may be removed or sampled.
Systemic Treatment
Advanced or recurrent leiomyosarcoma may be treated with medicines such as doxorubicin, gemcitabine with docetaxel, trabectedin, pazopanib or other sarcoma therapies. Low-grade endometrial stromal sarcoma is often hormone-receptor positive and may respond to aromatase inhibitors, progestins or ovarian suppression. Radiation may be used in selected higher-risk situations, for local recurrence or to control symptoms.
How Cancer Healer Therapy (CAM) Supports You
Cancer Healer Therapy (CAM) is supportive integrative care used alongside treatment prescribed by your gynaecologic and sarcoma oncology team, not instead of it.
The supportive plan may consider appetite, fatigue, sleep, emotional wellbeing, recovery after surgery and treatment-related discomfort.
Herbal medicines and supplements can interact with chemotherapy, hormone therapy, targeted medicines, blood thinners and surgical medicines.
Products marketed as supporting oestrogen or balancing female hormones may be particularly unsuitable for hormone-sensitive uterine sarcomas.
Support may begin before surgery, chemotherapy, hormone treatment or radiation, with attention to bleeding, pelvic symptoms, nutrition, organ function and current medicines.
Supportive care may focus on fatigue, appetite, nausea, bowel changes, pelvic discomfort, menopausal symptoms, sleep and emotional wellbeing.
Supportive care should not delay specialist pathology review, imaging, hysterectomy, systemic therapy, radiation or molecular testing.
Cancer Healer Therapy does not replace surgery, chemotherapy, hormone therapy, targeted treatment, radiation or surveillance.
Types of Uterine Sarcoma
- Uterine leiomyosarcoma: Develops from smooth-muscle cells and may spread through the bloodstream to distant organs.
- Low-grade endometrial stromal sarcoma: Usually grows slowly and is often hormone-receptor positive. Recurrence can occur years after treatment.
- High-grade endometrial stromal sarcoma: Generally behaves more aggressively and may have specific molecular alterations.
- Undifferentiated uterine sarcoma: A rare high-grade diagnosis requiring expert pathology review.
- Uterine adenosarcoma: May behave relatively slowly when low grade but can become more aggressive with sarcomatous overgrowth.
Rare molecularly defined tumours, including NTRK-rearranged sarcomas, may have specific targeted treatment options in advanced disease.
Stages
For leiomyosarcoma and endometrial stromal sarcoma, staging describes how far the cancer has spread.
- Stage I: Tumour remains limited to the uterus.
- Stage II: Tumour has extended beyond the uterus but remains within the pelvis.
- Stage III: Cancer has spread into abdominal tissues or regional lymph nodes.
- Stage IV: Cancer has invaded certain nearby organs or spread to distant sites.
Uterine adenosarcoma uses a separate staging system that also considers the depth of uterine muscle invasion. The oncology team determines the formal stage according to the specific uterine sarcoma subtype and clinical findings.
Signs and Symptoms
Possible signs and symptoms of uterine sarcoma include:
- Bleeding between periods
- Bleeding after menopause
- Heavy or prolonged periods
- Watery or blood-stained vaginal discharge
- A pelvic or abdominal mass
- Pelvic pressure or pain
- Increasing abdominal size
- Frequent urination or constipation
- Pain during intercourse
Advanced disease may cause persistent cough, breathlessness, unexplained weight loss or fatigue. These symptoms can have causes other than cancer, but postmenopausal bleeding, a new pelvic mass or persistent unexplained symptoms should always receive appropriate medical assessment.
Your Journey With Cancer Healer Center
Here’s exactly what happens from your first conversation with us to ongoing support during treatment.
01
Initial Consultation:
We discuss your diagnosis, pathology, scans, symptoms and current or planned treatment.
02
Comprehensive Assessment:
The team reviews the exact sarcoma subtype, stage, tumour size, margins, whether morcellation occurred, hormone receptors and molecular findings.
03
Personalised Cancer Healer Therapy (CAM) Plan:
Supportive care is developed around your surgery, systemic treatment or surveillance plan.
04
Safety and Coordination Review:
Herbal products, supplements and special diets should be disclosed to your treating oncology team.
05
Active Monitoring and Adaptation:
The plan may be reviewed as symptoms, imaging, organ function and treatment needs change.
06
Dedicated Coordinator:
One point of contact supports appointments and follow-up communication.
Why Choose Cancer Healer Center
Meet Dr. Tarang Krishna, MD - Cancer Healer Center
Dr. Tarang Krishna has spent over two decades developing and refining Cancer Healer Therapy, working with a multidisciplinary team across 30+ centres in India.
His work has been recognised for innovative cancer care and brings a coordinated, supportive approach to every patient journey.
Patient Experiences
Stories Shared by Patients and Families
Every cancer journey is personal. Read experiences shared by patients and families about the consultations, communication, follow-up and support they received at Cancer Healer Center.
4.9 Stars | 5479 Reviews
Pancreatic CancerI'm incredibly grateful to the team at Cancer Healer Center! 🌟 Their compassionate approach, cutting-edge treatments, and personalized care made all the difference in my uncle's journey. The doctors and staff were supportive, transparent, and truly invested in my well-being. Thanks to their expertise, I'm on the road to recovery.
ASAshish SinhaChandigarh- Blood Cancer
Cancer Healer Center is one of the best cancer treatment clinic in Chandigarh. The staff is compassionate, the doctors explain everything clearly, and the environment is very comforting for patients and families. Their unique treatment approach focuses on strengthening immunity along with medical support. I have deep respect for the entire team, and I’m extremely satisfied with the care and professionalism here.
AWAbhishek WaliaChandigarh I visited Cancer Healer Center at Juhu. I had a very good experience regarding my patient doubts. The doctor professionally explained all my concerns and clarified all the reports clearly. The staff was also polite and supportive. Highly recommend this center.
AAAnsari AqsaMumbai
FAQs
Frequently Asked Questions
No. Endometrial cancer begins in the uterine lining. Uterine sarcoma begins in muscle or supporting tissues and has different treatment pathways.
Ordinary fibroids are not generally believed to transform into leiomyosarcoma. Sarcoma usually develops as a separate tumour.
No. MRI and specialist imaging can identify suspicious features, but pathology is often needed for a definite diagnosis.
Cutting an unsuspected sarcoma into pieces can spread tumour cells through the abdomen and make staging and treatment more difficult.
No. Surveillance is often appropriate after complete surgery for Stage I leiomyosarcoma. Additional treatment depends on subtype, stage and recurrence risk.
Hormone therapy is particularly important for hormone-receptor-positive low-grade endometrial stromal sarcoma and may also be used for selected hormone-sensitive leiomyosarcomas or adenosarcomas.
Yes. High-grade sarcomas may recur earlier, while low-grade stromal sarcoma may return many years later. Long-term follow-up is important.
Some localised uterine sarcomas can be cured with complete surgery. Outcomes depend on subtype, stage, grade, surgical margins and tumour biology.
No. Cancer Healer Therapy is supportive integrative care used alongside treatment prescribed by the sarcoma and gynaecologic oncology team. It should not replace or delay recommended treatment.
Only after discussing every product with your oncologist or oncology pharmacist. Some products may interfere with chemotherapy or hormone therapy, affect liver or kidney function, or increase bleeding and clotting risks.